Kardium - About the company
Kardium is a series C company based in Burnaby (Canada), founded in 2007 by Dan Gelbart, Ruslan Nikolaev, Amos Michelson and Sam Lichtenstein. It operates as a Developer of ablation device for atrial fibrillation. Kardium has raised $471M in funding from investors like Fidelity Investments, T. Rowe Price and Janus Henderson Investors. The company has 16 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like Galvanize, Field Medical and Argá Medtech.
Company Details
Kardium is developing the Globe mapping and ablation system. It's an investigational medical device, used in the diagnosis and treatment of atrial fibrillation. It provides mapping, stimulation, and RF ablation of cardiac tissue.
- Website
- kardium.com
- Registered Address
- 2900 - 550 Burrard Street, Vancouver
Key Metrics
Founded Year
2007
Location
Burnaby, Canada
Stage
Series C
Total Funding
$471M in 6 rounds
Latest Funding Round
Investors
Ranked
1st among 16 active competitors
Employee Count
578 as on Mar 31, 2026
Legal entities associated with Kardium
Kardium is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Kardium Inc. CIN: 12611210 , Canada, Active | Jan 01, 2021 | - | - | - |
Sign up to download Kardium's company profile
Kardium's funding and investors
Kardium has raised a total funding of $471M over 6 rounds. Its first funding round was on Jul 22, 2010. Its latest funding round was a Series C round on Jul 08, 2025 for $*****. 7 investors participated in its latest round. Kardium has 12 institutional investors.
Here is the list of recent funding rounds of Kardium:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 08, 2025 | 3194643 | Series C | 9004556 | 4895736 | 3897802 | 4345164 |
Jun 11, 2024 | 6098545 | Series B | 3133321 | 4820959 | 7367303 | |
Dec 30, 2020 | 6919715 | Series B | 4279135 | 8578325 |
View details of Kardium's funding rounds and investors
Kardium's founders and board of directors
Founder? Claim ProfileHere are the details of Kardium's key team members:
- Dan Gelbart: Co-Founder of Kardium.
- Ruslan Nikolaev: Co-Founder of Kardium.
- Amos Michelson: Co-founder & Chairman of Kardium.
- Sam Lichtenstein: Co-Founder of Kardium.
View details of Kardium's Founder profiles and Board Members
Kardium's employee count trend
Kardium has 578 employees as of Mar 26. Here is Kardium's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Kardium's Competitors and alternates
Top competitors of Kardium include Galvanize, Field Medical and Argá Medtech. Here is the list of Top 10 competitors of Kardium, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of ablation device for atrial fibrillation | $471M | 64/100 | ||
2nd | Galvanize 2020, San Carlos (United States), Series C | Developer of pulsed electric field systems for various medical indications | $210M | 58/100 | |
3rd | Field Medical 2022, Encinitas (United States), Series B | Developer of device for the treatment of heart arrhythmia conditions | $75M | 56/100 | |
4th | Argá Medtech 2020, Epalinges (Switzerland), Series B | Developer of medical devices for treating cardiac arrhythmias | $58.5M | 55/100 | |
5th | Pulse Biosciences 2014, Burlingame (United States), Acquired | Developer of a platform technology called Nano-Pulse Electro-Signaling | $8M | 50/100 | |
6th | EnChannel Medical 2020, Ladera Ranch (United States), Series B | Developer of medical device for cardiac disorders | $110M | 48/100 | |
7th | Farapulse 2014, Menlo Park (United States), Series C | Advanced cardiac ablation solutions for atrial fibrillation treatment | $36.3M | 44/100 | |
8th | Affera 2014, Boston (United States), Acquired | Developer of devices to treat heart rhythm disorders | - | 43/100 | |
9th | Developing the device that targets to atrial fibrillation | $2.56M | 41/100 | ||
10th | R&D company focused on producing and supplying of medical devices | $103M | 32/100 |
Looking for more details on Kardium's competitors? Click here to see the top ones
Kardium's Investments and acquisitions
Kardium has made no investments or acquisitions yet.
News related to Kardium
Media has covered Kardium for a total of 11 events in the last 1 year, 6 of them have been about company updates.
•
Kardium Announces Publication of PULSAR Pivotal Trial Results in JACCFinancial Post•Jan 21, 2026•Kardium
•
•
Corline signs a ten-year license and supply agreement with AccessibilityGlobeNewswire•Sep 30, 2025•Corline Biomedical, Kardium
•
•
Kardium Secures $250M (CA$340M) to Launch Atrial Fibrillation Treatmentintelligence360•Jul 08, 2025•Eventide Asset Management, Eckuity, Qatar Investment Authority, Kardium
•
•
Corline's Customer Kardium Secures $250 Million Funding for Globe® LaunchGlobeNewswire•Jul 02, 2025•Kardium
•
•
Kardium Reports Strong One-Year Results and High Safety in PULSAR-IDE StudyGlobeNewswire•Apr 26, 2025•Kardium
•
Kardium Touts Enhanced Clinical Capabilities of the Globe SystemMedical Product Outsourcing•Jun 14, 2024•Kardium
Are you a Founder ?
FAQs about Kardium
Explore our recently published companies
- Convex - London based, 2019 founded, Acquired company
- Cold Solutions Kenya - Kiambu based, 2020 founded, Series B company
- Apollo Diamond - Boston based, 1990 founded, Funding Raised company
- CLARKDALE WATER ASSOCIATION - United States based, Funding Raised company
- Ira H. Hayes Memorial Applied Learning Center - United States based, Funding Raised company
- Qtrack.com - 2021 founded, Funding Raised company